TSUSF (Tsuruha Holdings) EV-to-EBITDA: 9.41 (As of Jul. 24, 2026) — 24% Below Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSUSF Tsuruha Holdings Inc TSUSF
47 GF Score
Price $17.25
GF Value $11.49
! 6 Warning Signs
View Full Analysis

What is Tsuruha Holdings EV-to-EBITDA?

Tsuruha Holdings TSUSF 47 EV-to-EBITDA is 9.41 as of Jul. 24, 2026, which is 24% below its 10-year median of 12.43. GuruFocus rates TSUSF with a GF Score™ of 47/100 and a GF Value™ of $11.49. The stock has 6 warning signs investors should review. Among 507 Healthcare Providers & Services companies, Tsuruha Holdings ranks better than 56.21% on this metric.

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Tsuruha Holdings's enterprise value is $6,523 Mil. Tsuruha Holdings's EBITDA for the trailing twelve months (TTM) ended in Feb. 2026 was $693 Mil. Therefore, Tsuruha Holdings's EV-to-EBITDA for today is 9.41.

The historical rank and industry rank for Tsuruha Holdings's EV-to-EBITDA or its related term are showing as below:

TSUSF' s EV-to-EBITDA Range Over the Past 10 Years
Min: 6.92   Med: 12.43   Max: 20.15
Current: 10.04

During the past 13 years, the highest EV-to-EBITDA of Tsuruha Holdings was 20.15. The lowest was 6.92. And the median was 12.43.

TSUSF's EV-to-EBITDA is ranked better than
56.21% of 507 companies
in the Healthcare Providers & Services industry
Industry Median: 10.92 vs TSUSF: 10.04

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2026-07-24), Tsuruha Holdings's stock price is $17.25. Tsuruha Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Feb. 2026 was $0.836. Therefore, Tsuruha Holdings's PE Ratio (TTM) for today is 20.63.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio (TTM).


Tsuruha Holdings  (OTCPK:TSUSF) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Tsuruha Holdings's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=17.25/0.836
=20.63

Tsuruha Holdings's share price for today is $17.25.
Tsuruha Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Feb. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.836.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).

Please read Which price ratio outperforms the enterprise multiple?


Tsuruha Holdings EV-to-EBITDA Related Terms


Tsuruha Holdings EV-to-EBITDA Historical Data

* Premium members only.

The historical data trend for Tsuruha Holdings's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Tsuruha Holdings EV-to-EBITDA Chart

Tsuruha Holdings Annual Data
Trend May16 May17 May18 May19 May20 May21 May22 May23 May24 Feb26
EV-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only 9.83 5.54 7.67 8.09 12.21

Tsuruha Holdings Quarterly Data
Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25 May25 Aug25 Nov25 Feb26 May26
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.29 7.02 9.65 12.21 0.00

Tsuruha Holdings EV-to-EBITDA Competitor Comparison

For the Pharmaceutical Retailers subindustry, Tsuruha Holdings's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tsuruha Holdings EV-to-EBITDA vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Tsuruha Holdings's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Tsuruha Holdings's EV-to-EBITDA falls into.


TSUSF
47GF Score
Tsuruha Holdings Inc TSUSF
EV-to-EBITDA is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Tsuruha Holdings EV-to-EBITDA Calculation

Tsuruha Holdings's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=6523.314/693.141
=9.41

Tsuruha Holdings's current Enterprise Value is $6,523 Mil.
Tsuruha Holdings's EBITDA for the trailing twelve months (TTM) ended in Feb. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $693 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EV-to-EBITDA →
What does a EV-to-EBITDA of 9.41 mean?
Tsuruha Holdings (TSUSF) has a EV-to-EBITDA of 9.41 as of Jul. 24, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Tsuruha Holdings. This is 24% below median its historical median of 12.43. Over the past decade, Tsuruha Holdings' EV-to-EBITDA has ranged from 6.92 to 20.15. According to the industry distribution chart, Tsuruha Holdings ranks #222 out of 507 companies in the Healthcare Providers & Services industry, placing it in the top 43.8%.
Is Tsuruha Holdings' EV-to-EBITDA too high?
Tsuruha Holdings' current EV-to-EBITDA of 9.41 is 24% below median its 10-year median of 12.43. Over the past 10 years, this metric has ranged from a low of 6.92 to a high of 20.15. The Healthcare Providers & Services industry median EV-to-EBITDA is 10.92. Tsuruha Holdings' value of 9.41 is 13.8% below this industry median. Based on the distribution chart, Tsuruha Holdings ranks #222 out of 507 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Tsuruha Holdings has a GF Score™ of 47/100, reflecting its overall financial health beyond just this single metric.
How does Tsuruha Holdings' EV-to-EBITDA compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Tsuruha Holdings ranks #222 out of 507 companies for EV-to-EBITDA. This puts Tsuruha Holdings in the upper half of its industry. The industry median EV-to-EBITDA is 10.92. Tsuruha Holdings' value of 9.41 is 13.8% below this benchmark. Historically, Tsuruha Holdings' own EV-to-EBITDA has ranged from 6.92 to 20.15 over the past decade. While the company's 10-year median is 12.43 vs. the industry median of 10.92, Tsuruha Holdings has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Healthcare Providers & Services company?
The median EV-to-EBITDA among Healthcare Providers & Services companies is 10.92, based on 507 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Tsuruha Holdings's current EV-to-EBITDA of 9.41 is 13.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Tsuruha Holdings. For the Healthcare Providers & Services industry, the median EV-to-EBITDA is 10.92 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Tsuruha Holdings's current EV-to-EBITDA is 9.41, which is 24% below median its own 10-year median of 12.43. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tsuruha Holdings stock overvalued right now?
Tsuruha Holdings (TSUSF) has a current EV-to-EBITDA of 9.41. The stock's GF Value™ is $11.49, compared to a current price of $17.25 — trading 50.1% above its estimated fair value. The current EV-to-EBITDA is 9.41, which is 24% below median its 10-year median of 12.43 and 13.8% below the Healthcare Providers & Services industry median of 10.92. Tsuruha Holdings' overall GF Score™ is 47/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Tsuruha Holdings (TSUSF), the current EV-to-EBITDA is 9.41 as of Jul. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Tsuruha Holdings (TSUSF) Overvalued in 2026?

Based on GuruFocus' analysis, Tsuruha Holdings stock appears to be overvalued. The current stock price of $17.25 is trading 50.1% above its estimated GF Value™ of $11.49.

Key valuation signals for TSUSF:

  • EV-to-EBITDA: 9.41 (24% below median its 10-year median of 12.43)
  • GF Value™: $11.49 vs. price of $17.25 (50.1% above fair value)
  • GF Score™: 47/100 with 6 warning signs
  • Industry Position: 13.8% below the Healthcare Providers & Services median (#222 of 507)

No single metric tells the full story. See the TSUSF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Tsuruha Holdings Business Description

Other Exchanges 3391:Japan
Address Kita 24-jo Higashi 20-chome, Higashi-ku, Sapporo, JPN, 065-0024
Tsuruha Holdings Inc manages pharmaceutical companies in Japan, where the drugstore business is the core of their operations. The company generates revenue through selling prescription and over-the-counter drugs, medical supplies, nursing care products, discount cosmetics, health products, and a miscellaneous assortment of general merchandise. It also provides blood testing services, disease prevention solutions, and at-home drug delivery services.
47GF Score

Get the complete analysis for TSUSF

EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$17.25
Price
$11.49
GF Value